Interleukin-17 alleviates erastin-induced alveolar bone loss by suppressing ferroptosis via interaction between NRF2 and p-STAT3

CONCLUSIONS: IL-17 administration conferred resistance to erastin-induced osteoblast ferroptosis and osteogenesis. The possible mechanism may involve p-STAT3 directly interacting with NRF2.PMID:37961757 | DOI:10.1111/jcpe.13898
Source: Journal of Clinical Periodontology - Category: Dentistry Authors: Source Type: research